Zhicheng Sun

Sep 3, 2024 | journals.plos.org | Qiushi Wang |Zhicheng Sun |Yueming Zhu

Loading metrics Open Access Peer-reviewedResearch Article Citation: Wang Q, Sun Z, Zhu Y, Li D, Ma Y (2024) A fault diagnosis method based on an improved diffusion model under limited sample conditions. PLoS ONE 19(9): e0309714. https://doi.org/10.1371/journal.pone.0309714Editor: Lei Zhang, Beijing Institute of Technology, CHINAReceived: April 29, 2024; Accepted: August 14, 2024; Published: September 3, 2024Copyright: © 2024 Wang et al.

Apr 15, 2024 | nature.com | Zhongchao Li |Bo Zhang |Xuetao Shi |Kai Cui |Zhicheng Sun |Mingming Li | +3 more

AbstractNotable-HCC (NCT05185531) is a phase 1b trial, aiming to evaluate the safety and preliminary effectiveness of neoadjuvant PD-1 blockade plus stereotactic body radiotherapy (SBRT) in early-stage resectable hepatocellular carcinoma (HCC). Twenty patients with HCC of BCLC stage 0-A received 3\(\times \) Gy SBRT and two cycles of tislelizumab, an anti-PD-1 monoclonal antibody before the curative HCC resection.